The nation of Zimbabwe has rejected a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years over the United States' demand for sensitive information.
This move was revealed following a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
An official spokesperson later explained that the United States was requesting biological samples for research and commercial purposes but was unwilling to guarantee the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable task of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had provided over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for continued talks to secure a deal suitable to both sides so the country's critical HIV treatment initiative can continue.
Broader Context
This rejection follows a similar case in Kenya, where a court blocked a related health funding agreement following concerns were filed about the safety of citizens' medical information.
Since resuming office last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump claimed its spending was "inefficient" and his government was seeking direct bilateral agreements to enhance transparency and accountability.
According to statements, 16 nations in Africa have so far agreed to similar agreements, constituting over $18.3bn in new funding.
Specifics of the Declined Deal
The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million presently on HIV treatment via US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to surrender its genetic material and health information indefinitely, with no equivalent assurance of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," his statement read.
"Put simply, our nation would supply the raw materials for scientific discovery with no certainty that the end products would be available to our population should a future health crisis arise."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its push of bilateral health agreements were upending structures already set up via the global health agency.
Mangwana cited its Pandemic Benefit-Sharing system designed to deal with future global health emergencies.
"This framework is intended to guarantee that when a country provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the resources to create them."
These objections over the US deal "are not meant as hostility towards the US," he added.
"We encourage ongoing dialogue with our US partners on how future co-operation might be structured in a manner that respects the sovereignty and interests of each country."
Medical Community Reaction
A leading public health body stated it understood the official position, but urged that negotiations should continue since much of the country's HIV programmes relied on external financing.
"In cases where technical issues arise, including those involving information security or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," the group commented.
The situation highlights the ongoing challenges between receiving crucial international aid and safeguarding national sovereignty in an ever more interconnected world.